TY - JOUR
T1 - Synchronized release of Doxil and Nutlin-3 by remote degradation of polysaccharide matrices and its possible use in the local treatment of colorectal cancer
AU - Nadler-Milbauer, Mirela
AU - Apter, Lior
AU - Haupt, Ygal
AU - Haupt, Sue
AU - Barenholz, Yechezkel
AU - Minko, Tamara
AU - Rubinstein, Abraham
PY - 2011
Y1 - 2011
N2 - This study focused on developing multicompartment vehicles capable of carrying drug cargos of different nature that, upon collapse, disperse their loads evenly, thereby causing them to function concomitantly at the same location (Nadler-Milbauer, 2009). Specifically, we focused our efforts on a hydrogel (alginate beads) with the intention of targeting the intestinal mucosa
with a combination of cytotoxic agents in the context of micro-disease recurrence prevention after malignant polyp removal in CRC. This approach is meritorious for other medical applications. For example, we have
already demonstrated that a concomitant release of poorly absorbed drugs and absorption enhancers or P-glycoprotein inhibitors significantly increased the
drug bioavailability after intestinal administration in rats (Baluom et al., 2001).
AB - This study focused on developing multicompartment vehicles capable of carrying drug cargos of different nature that, upon collapse, disperse their loads evenly, thereby causing them to function concomitantly at the same location (Nadler-Milbauer, 2009). Specifically, we focused our efforts on a hydrogel (alginate beads) with the intention of targeting the intestinal mucosa
with a combination of cytotoxic agents in the context of micro-disease recurrence prevention after malignant polyp removal in CRC. This approach is meritorious for other medical applications. For example, we have
already demonstrated that a concomitant release of poorly absorbed drugs and absorption enhancers or P-glycoprotein inhibitors significantly increased the
drug bioavailability after intestinal administration in rats (Baluom et al., 2001).
UR - http://informahealthcare.com/doi/pdf/10.3109/1061186X.2011.622401
U2 - 10.3109/1061186X.2011.622401
DO - 10.3109/1061186X.2011.622401
M3 - Article
SN - 1061-186X
VL - 19
SP - 859
EP - 873
JO - Journal of Drug Targeting
JF - Journal of Drug Targeting
IS - 10
ER -